AbbVie has filed multiple material events (8-K filings) related to Allergan Aesthetics in recent months, with filings dated April 29, May 12, and June 22, 2026. While specific details are not yet public, SEC material event disclosures typically signal pricing adjustments, rebate program restructuring, or competitive moves affecting the Allē loyalty platform.